Shares of Smith & Nephew plc (NYSE:SNN – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the five analysts that are covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold rating and three have issued a buy rating on the company.
A number of brokerages have issued reports on SNN. StockNews.com cut shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Monday, May 13th. UBS Group raised shares of Smith & Nephew from a “neutral” rating to a “buy” rating in a report on Wednesday, June 5th.
View Our Latest Analysis on SNN
Institutional Investors Weigh In On Smith & Nephew
Smith & Nephew Trading Up 0.4 %
Shares of NYSE SNN opened at $28.40 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.77 and a quick ratio of 0.72. The firm’s 50-day moving average price is $25.60 and its two-hundred day moving average price is $26.24. Smith & Nephew has a 52-week low of $21.52 and a 52-week high of $31.31.
About Smith & Nephew
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Featured Stories
- Five stocks we like better than Smith & Nephew
- What Are Growth Stocks and Investing in Them
- MarketBeat Week in Review – 7/8 – 7/12
- 3 Best Fintech Stocks for a Portfolio Boost
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- ESG Stocks, What Investors Should Know
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.